Frederick Vogt

Track

Insider profile

Currently holds a position at Iovance Biotherapeutics Inc

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 34% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
General Counsel, Corporate Secretary Iovance Biotherapeutics Inc Jan. 1, 2019 -
Frederick Vogt's trades of Iovance Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
388.97
Quantity 76,602 -16.6%
Value US$4,905,268
Transaction date
Purchase
Price
41.58
Quantity 73,809 -35.7%
Value US$2,103,674
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-16 2025-05-14
B Purchase
15,007 +26.4%
10.63
US$4,039,378 		15,007 +26.4% 10.63 US$4,039,378
2022-11-28 2022-11-28
B Purchase
76,602 -16.6%
388.97
US$4,905,268 		76,602 -16.6% 388.97 US$4,905,268
2022-06-02 2022-06-01
B Purchase
73,809 -35.7%
41.58
US$2,103,674 		73,809 -35.7% 41.58 US$2,103,674